Global Interventional Neurology Devices Market - Segmented by Product Type, Application, and Geography - Growth, Trends, and Forecast (2022 - 2030)
The global interventional neurology devices market is expected to register a CAGR of 7.5% during the forecast period, (2018 -2023). The Asia-Pacific is anticipated to grow significantly during the forecast period, owing to rising incidence of neurological diseases and less stringent regulatory scenario.
Increasing Incidence of Neurological Disorders
According to a study published in the April 2017, in the Journal of the Annals of Neurology, the most common neurological diseases cost USD 789 billion, in 2014, in the United States, and is expected to grow in the future, due to the rising elderly populations. According to data from the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people died from Alzheimer’s disease in 2013. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases. Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. The increasing incidences of neurological disorders is driving the market. Additionally, the increasing demand for minimally invasive treatment, increasing R&D investment for neurotherapies from key players, and rising elderly population is likely to drive the market growth for interventional neurology devices, globally.
Stringent Regulatory Guidelines
Food and Drug Administration (FDA) strictly regulates the approval of medical devices depending on their class. There is relatively few class I neurological devices. Majority of the neurological devices are classified under Class II and Class III. Some of the Class I devices include ventricular needles and anvils used to form skull plates. Class II devices include neurostimulators, aneurysm clips, and blood clot retrievers. Examples of Class III devices are deep brain stimulators and medical devices for the treatment of brain tumors. Approval of class III medical devices is complicated and requires clinical trials. The time taken for the trials can 36 months or more, depending on the extent of clinical trials and additional information that FDA might request. European Union has recently taken steps to strengthen its regulatory approval process significantly, and this is expected to delay approvals in Europe. The delay in regulatory approvals and high cost of interventional devices are the major challenges faced by the companies involved in the manufacture of neurological devices.
North America to Dominate the Market
North America is expected to hold the largest share of neurovascular devices market during the forecast period. The factors, such as significant adoption of neurovascular devices among neurosurgeons, favorable reimbursement scenario, the presence of established key players in the region, and huge investment in R&D are driving the growth of the North American interventional neurology market.
Key Developments in the Market
• January 2018: Medtronic received US FDA clearance for Riptide aspiration system intended for use in the revascularization of patients with acute ischaemic stroke secondary to large intracranial vessel occlusive disease
• July 2017: Johnson & Johnson Medical Devices Companies recently introduced CERENOVUS, its new neurovascular business.
Major Players: ABBOTT, B. BRAUN MELSUNGEN AG, PENUMBRA, INC., BOSTON SCIENTIFIC CORPORATION, JOHNSON & JOHNSON, MEDTRONIC, INC., MERIT MEDICAL SYSTEMS., STRYKER CORPORATION, TERUMO CORPORATION AND WL GORE & ASSOCIATES., amongst others.
Reasons to Purchase the Report
• Current and future global interventional neurology devices market outlook, in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Increasing Incidence of Neurological Disorders
According to a study published in the April 2017, in the Journal of the Annals of Neurology, the most common neurological diseases cost USD 789 billion, in 2014, in the United States, and is expected to grow in the future, due to the rising elderly populations. According to data from the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people died from Alzheimer’s disease in 2013. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases. Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. The increasing incidences of neurological disorders is driving the market. Additionally, the increasing demand for minimally invasive treatment, increasing R&D investment for neurotherapies from key players, and rising elderly population is likely to drive the market growth for interventional neurology devices, globally.
Stringent Regulatory Guidelines
Food and Drug Administration (FDA) strictly regulates the approval of medical devices depending on their class. There is relatively few class I neurological devices. Majority of the neurological devices are classified under Class II and Class III. Some of the Class I devices include ventricular needles and anvils used to form skull plates. Class II devices include neurostimulators, aneurysm clips, and blood clot retrievers. Examples of Class III devices are deep brain stimulators and medical devices for the treatment of brain tumors. Approval of class III medical devices is complicated and requires clinical trials. The time taken for the trials can 36 months or more, depending on the extent of clinical trials and additional information that FDA might request. European Union has recently taken steps to strengthen its regulatory approval process significantly, and this is expected to delay approvals in Europe. The delay in regulatory approvals and high cost of interventional devices are the major challenges faced by the companies involved in the manufacture of neurological devices.
North America to Dominate the Market
North America is expected to hold the largest share of neurovascular devices market during the forecast period. The factors, such as significant adoption of neurovascular devices among neurosurgeons, favorable reimbursement scenario, the presence of established key players in the region, and huge investment in R&D are driving the growth of the North American interventional neurology market.
Key Developments in the Market
• January 2018: Medtronic received US FDA clearance for Riptide aspiration system intended for use in the revascularization of patients with acute ischaemic stroke secondary to large intracranial vessel occlusive disease
• July 2017: Johnson & Johnson Medical Devices Companies recently introduced CERENOVUS, its new neurovascular business.
Major Players: ABBOTT, B. BRAUN MELSUNGEN AG, PENUMBRA, INC., BOSTON SCIENTIFIC CORPORATION, JOHNSON & JOHNSON, MEDTRONIC, INC., MERIT MEDICAL SYSTEMS., STRYKER CORPORATION, TERUMO CORPORATION AND WL GORE & ASSOCIATES., amongst others.
Reasons to Purchase the Report
• Current and future global interventional neurology devices market outlook, in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
